CJC-1295 (No DAC) combined with Ipamorelin represents a synergistic growth hormone secretagogue stack. CJC-1295 without DAC (Drug Affinity Complex) is a modified form of GHRH (1-29) that stimulates growth hormone release from the pituitary. Ipamorelin is a selective growth hormone secretagogue that mimics ghrelin without significantly affecting cortisol or prolactin levels. This combination allows researchers to study the complementary effects of GHRH and GHRP pathways simultaneously. The blend is popular in research examining growth hormone pulsatility and metabolic effects.